3D打印的平板电脑用于使用选择性激光烧结来个性化定位普得尼松剂量
Zheng Zheng1, Liam Krueger1, Angus C F Harrop1
1School of Pharmacy and Pharmaceutical Sciences, The University of Queensland, Woolloongabba, QLD 4102, Australia.
International journal of pharmaceutics
|May 9, 2025
概括
3D打印可以实现个性化的药物治疗. 选择性激光烧结 (SLS) 成功创建了符合质量标准的定制剂量的药片,为改善患者坚持治疗提供了标准药片的可行替代品.
科学领域:
- 制药技术 制药技术 制药技术
- 增材制造 增材制造 增材制造
- 材料科学 材料科学 材料科学
背景情况:
- 标准化药物剂量可以导致患者不良的药物坚持和不良影响.
- 普雷尼松是一种类固醇抗炎药物,通常需要复杂的剂量方案.
- 3D打印为个性化医疗和精确的药物输送提供了潜力.
研究的目的:
- 调查选择性激光烧结 (SLS) 3D打印的使用,以生产定量剂量的普雷尼松片.
- 评估3D打印的普得尼松片的质量和药物释放特征.
- 为了证明3D打印用于个性化药物的临床可行性.
主要方法:
- 使用选择性激光烧结 (SLS) 3D打印技术.
- 使用不同尺寸的3D模型生产了五种不同剂量的普得尼松片 (5-25毫克).
- 根据英国药典标准评估药片质量,并评估药物释放概况.
主要成果:
- 在五个不同的剂量组中成功打印出定制的普雷尼松片,准确度高.
- SLS打印片符合传统制造和英国药典的质量标准.
- 药片表现出立即释放的特征,药物在25分钟内完全释放,类似于商业普得尼松片.
结论:
- 选择性激光烧结 (SLS) 3D打印能够生产定制治疗剂量的普雷尼松.
- 这项技术证明了在个性化药物输送中临床翻译的可行性.
- 3D打印的个性化药物提供了一个有希望的转变,从标准化剂量.
相关概念视频
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Dosage Regimen Designs: Nomograms and Tabulations
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...


